Comparison Chart Savara Inc.

Stocks

SVRA

US8051111016

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 15:31:21 2026-11-09 EST			5-day change	1st Jan Change
5.035 ^USD	+4.24%		+6.03%	-16.83%

10-21	Savara Inc. Presents New Data Showing Molgramostim Inhalation Solution Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis Patients with Mild Diffusion Impairment	CI
10-12	Savara Inc. Announces New Analysis From The IMPALA Clinical Trial And Encore Presentation Of Long-Term Data On Molgramostim In Autoimmune Pulmonary Alveolar Proteinosis At CHEST 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SAVARA INC.	Bio Therapeutic Drugs	+4.14%	+6.03%	-16.83%	+25.38%	+332.33%	1.23B